4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000114
Chief Technology Officer sold 2,595 shares at $28.94 ($75,099)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stout Jay S Chief Technology Officer | 2026-10-21 | Sale | −2,595 | $28.94 | $75,099 | 198,937 | D |
| Open-market sales · 2,595 sh · avg $28.94 · $75,099 | |||||||
Loading xslF345X06/wk-form4_1792788920.xml…